查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1397016

全球听力植入市场：按产品、应用和最终用户 - 机会分析和行业预测，2023-2032 年

Hearing Implants Market By Product, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032
出版日期: | 出版商: Allied Market Research | 英文 334 Pages | 商品交期: 2-3个工作天内

价格

预计2022年全球听力植入市场规模将达17.3333亿美元，2023年至2032年复合年增长率为8.2%，2032年将达381936万美元。

听力植入是医疗设备，旨在透过直接刺激听觉系统来解决严重至极重度听力损失。透过手术植入耳朵或耳蜗，它绕过自然听觉途径的受损部分（例如毛细胞），并以电子方式刺激听觉神经，从而感知声音。当传统助听器因听力损失的严重程度或解剖学限製而无法满足要求时，通常会考虑使用此方法。人工电子耳就是一个典型的例子，由外部处理器和内部植入组件组成。处理器捕捉声音，对其进行处理，并将声音传输到植入的电极，直接刺激听觉神经。这种方法可以改善语音感知和声音识别，显着提高重度听力损失患者的沟通能力和整体生活品质。

听力植入市场是由常见的听力损失病例和不断增加的老年人口推动的。此外，儿童听力损失病例的增加进一步推动了市场的成长。例如，根据美国美国耳聋和其他沟通障碍研究所 2021 年的报告，美国12 岁以上的人口中，八分之一（13%，即 3000 万人）的标准 A 听力测试显示双耳听力损失。此外，45 岁至 54 岁之间的成年人中约有 2% 患有听力损失。 55 至 64 岁成年人的听力损失率增至 8.5%。

此外，创新听力植入技术的出现进一步推动了市场成长。进步包括诸如在具有挑战性的听觉环境中改进的语音辨识、无线连接和创新的语音处理演算法等功能。这些创新满足了不同使用者的需求和偏好，并吸引了许多寻求有效解决听力损失问题的人的兴趣和支持。

此外，旨在提高人们对早期治疗选择的认识的政府配合措施的激增也发挥了至关重要的作用。这些配合措施强调了早期疗育的重要性和听力植入的好处，并鼓励及时咨询。此外，植入选择的广泛性和植入治疗保险范围的扩大也大大增加了对植入的需求。报销政策带来的经济便利性使听力植入成为更广泛人群的可行解决方案，并正在推动市场成长。

然而，有些人可能会犹豫是否选择助听器，因为植入助听器的手术有其固有风险。此外，由于解剖学限制和医疗条件等因素，并非每个人都是候选人。听力植入和相关手术的高昂成本给许多潜在使用者带来了经济障碍。此外，持续的维护要求和潜在的植入后併发症可能会阻碍采用。因此，上述因素预计将抑制市场成长。

目录

第一章简介

第 2 章执行摘要

第三章市场概况

  • 市场定义和范围
  • 主要发现
    • 主要影响因素
    • 关键投资机会
  • 波特五力分析
  • 市场动态
    • 促进因素
      • 听力损失盛行率增加
      • 老年人口增加
      • 听力植入技术的进步
    • 抑制因素
      • 植入适应症有限
      • 与手术相关的风险
    • 机会
      • 新兴国家的机会

第四章听力植入市场：副产品

  • 概述
  • 人工电子耳
  • 骨传导装置
  • 中耳植入
  • 听觉脑干植入

第五章听力植入市场：依应用分类

  • 概述
  • 感觉神经性的
  • 电导率

第六章听力植入市场：依最终使用者分类

  • 概述
  • 医院
  • 耳鼻喉科门诊
  • 门诊手术中心

第七章听力植入市场：依地区

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 其他亚太地区
  • 拉丁美洲、中东、非洲
    • 巴西
    • 沙乌地阿拉伯
    • 南非
    • 拉丁美洲其他地区、中东、非洲

第八章竞争形势

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争仪表板
  • 竞争热图
  • 2022年主要企业定位

第九章 公司简介

  • Cochlear Limited
  • MED-EL Elektromedizinische Gerate Gesellschaft mbH
  • Sonova Holding AG
  • Medtronic plc
  • Zhejiang Nurotron Biotechnology Co., Ltd
  • Envoy Medical
  • Ototronix, LLC
  • Todoc co. ltd
  • Neubio AG.
  • Hemideina
Product Code: A01689

The hearing implants market was valued for $1,733.33 million in 2022 and is estimated to reach $3,819.36 million by 2032, exhibiting a CAGR of 8.2% from 2023 to 2032.

A hearing implant is a medical device designed to address severe to profound hearing loss by directly stimulating the auditory system. It is surgically implanted within the ear or cochlea, and bypasses damaged parts of the natural auditory pathway, such as the hair cells, and electronically stimulates the auditory nerve, enabling sound perception. This solution is typically considered when traditional hearing aids are insufficient due to the extent of hearing loss or anatomical limitations. Cochlear implants are prominent examples, consisting of an external processor and internal implant components. The processor captures and processes sound, which is then transmitted to electrodes of the implant for direct stimulation of the auditory nerve. This approach offers improved speech perception and sound awareness, significantly enhancing communication abilities and overall quality of life for individuals with profound hearing impairment.

The hearing implants market is driven by the prevailing cases of hearing disorders and the growth in geriatric population. Furthermore, growth in cases of hearing disorder in the children further drive the market growth. For instance, according to National Institute of Deafness and other Communication Disorders report in 2021, stated that one in eight people in the U.S. (13 percent, or 30 million) aged 12 years or older has hearing loss in both ears, based on standard hearing examinations. About 2 percent of adults aged 45 to 54 have disabling hearing loss. The rate increases to 8.5 percent for adults aged 55 to 64.

Furthermore, the availability of innovative hearing implant technologies further drives the market growth. The advancements encompass features such as improved speech recognition in challenging auditory environments, wireless connectivity, and innovative sound processing algorithms. These innovations cater to diverse user needs and preferences, fostering interest and uptake among a broader audience seeking effective solutions to their hearing impairment.

Moreover, the surge in government initiatives aimed at growing awareness about early treatment options plays a pivotal role. These initiatives underscore the importance of early intervention and the benefits of hearing implants, encouraging individuals to seek prompt medical attention. In addition, the range of available hearing implant options, coupled with the expansion of reimbursement coverage for implantable procedures, has significantly fueled the demand for these devices. The financial accessibility brought about by reimbursement policies has rendered hearing implants a viable solution for a wider demographic, promoting market growth.

However, surgical procedures to implant these devices carry inherent risks, deterring some individuals from opting for them. Moreover, not everyone qualifies as a candidate due to factors such as anatomical limitations or medical conditions. The high cost of hearing implants and related procedures poses a financial barrier for many potential users. In addition, the necessity for ongoing maintenance and potential complications post-implantation can deter adoption. Thus, the aforementioned factors are anticipated to restrain the market growth.

The hearing implants market is segmented based on product, application, end user and region. On the basis of product, the market is categorized into cochlear implant, middle ear implant, bone conduction implant and auditory brainstem implant. On the basis of application, the market is bifurcated into conductive and sensorineural. On the basis of end user, the market is fragmented into hospitals, ENT clinics and ambulatory surgical centers (ASCs). On the basis of region, the market is studied across North America, Europe, Asia-Pacific, and LAMEA.

Major players that operate in the hearing implants market include Cochlear Limited, Medtronic plc, Envoy Medical, MED-EL, Sonova Holding AG, Zhejiang Nurotron Biotechnology Co., Ltd, Ototronix, LLC, Todoc Co. Ltd, Neubio AG. and Hemideina

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the hearing implants market analysis from 2022 to 2032 to identify the prevailing hearing implants market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the hearing implants market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global hearing implants market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Additional company profiles with specific to client's interest
  • Expanded list for Company Profiles
  • Historic market data

Key Market Segments

By End User

  • Hospitals
  • ENT Clinics
  • Ambulatory Surgical Centers

By Product

  • Bone Conduction Devices
  • Middle Ear Implants
  • Auditory Brain Stem Implants
  • Cochlear Implants

By Application

  • Sensorineural
  • Conductive

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Sonova Holding AG
    • Todoc co. ltd
    • Hemideina
    • Neubio AG.
    • Cochlear Limited
    • Medtronic plc
    • Ototronix, LLC
    • Envoy Medical
    • MED-EL Elektromedizinische Gerate Gesellschaft m.b.H.
    • Zhejiang Nurotron Biotechnology Co., Ltd

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Moderate bargaining power of suppliers
    • 3.3.2. High threat of new entrants
    • 3.3.3. Moderate threat of substitutes
    • 3.3.4. Moderate intensity of rivalry
    • 3.3.5. Moderate bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Increase in prevalence of hearing disorders
      • 3.4.1.2. Growth in geriatric population
      • 3.4.1.3. Technological advancements in hearing implants
    • 3.4.2. Restraints
      • 3.4.2.1. Limited candidacy for implantations
      • 3.4.2.2. Risk associated with surgeries
    • 3.4.3. Opportunities
      • 3.4.3.1. Opportunities in emerging countries

CHAPTER 4: HEARING IMPLANTS MARKET, BY PRODUCT

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Cochlear Implants
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Bone Conduction Devices
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Middle Ear Implants
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country
  • 4.5. Auditory Brain Stem Implants
    • 4.5.1. Key market trends, growth factors and opportunities
    • 4.5.2. Market size and forecast, by region
    • 4.5.3. Market share analysis by country

CHAPTER 5: HEARING IMPLANTS MARKET, BY APPLICATION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Sensorineural
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Conductive
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country

CHAPTER 6: HEARING IMPLANTS MARKET, BY END USER

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Hospitals
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. ENT Clinics
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Ambulatory Surgical Centers
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country

CHAPTER 7: HEARING IMPLANTS MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by Product
    • 7.2.3. Market size and forecast, by Application
    • 7.2.4. Market size and forecast, by End User
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Market size and forecast, by Product
      • 7.2.5.1.2. Market size and forecast, by Application
      • 7.2.5.1.3. Market size and forecast, by End User
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Market size and forecast, by Product
      • 7.2.5.2.2. Market size and forecast, by Application
      • 7.2.5.2.3. Market size and forecast, by End User
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Market size and forecast, by Product
      • 7.2.5.3.2. Market size and forecast, by Application
      • 7.2.5.3.3. Market size and forecast, by End User
  • 7.3. Europe
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by Product
    • 7.3.3. Market size and forecast, by Application
    • 7.3.4. Market size and forecast, by End User
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Market size and forecast, by Product
      • 7.3.5.1.2. Market size and forecast, by Application
      • 7.3.5.1.3. Market size and forecast, by End User
      • 7.3.5.2. France
      • 7.3.5.2.1. Market size and forecast, by Product
      • 7.3.5.2.2. Market size and forecast, by Application
      • 7.3.5.2.3. Market size and forecast, by End User
      • 7.3.5.3. UK
      • 7.3.5.3.1. Market size and forecast, by Product
      • 7.3.5.3.2. Market size and forecast, by Application
      • 7.3.5.3.3. Market size and forecast, by End User
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Market size and forecast, by Product
      • 7.3.5.4.2. Market size and forecast, by Application
      • 7.3.5.4.3. Market size and forecast, by End User
      • 7.3.5.5. Spain
      • 7.3.5.5.1. Market size and forecast, by Product
      • 7.3.5.5.2. Market size and forecast, by Application
      • 7.3.5.5.3. Market size and forecast, by End User
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Market size and forecast, by Product
      • 7.3.5.6.2. Market size and forecast, by Application
      • 7.3.5.6.3. Market size and forecast, by End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by Product
    • 7.4.3. Market size and forecast, by Application
    • 7.4.4. Market size and forecast, by End User
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Market size and forecast, by Product
      • 7.4.5.1.2. Market size and forecast, by Application
      • 7.4.5.1.3. Market size and forecast, by End User
      • 7.4.5.2. China
      • 7.4.5.2.1. Market size and forecast, by Product
      • 7.4.5.2.2. Market size and forecast, by Application
      • 7.4.5.2.3. Market size and forecast, by End User
      • 7.4.5.3. India
      • 7.4.5.3.1. Market size and forecast, by Product
      • 7.4.5.3.2. Market size and forecast, by Application
      • 7.4.5.3.3. Market size and forecast, by End User
      • 7.4.5.4. Australia
      • 7.4.5.4.1. Market size and forecast, by Product
      • 7.4.5.4.2. Market size and forecast, by Application
      • 7.4.5.4.3. Market size and forecast, by End User
      • 7.4.5.5. South Korea
      • 7.4.5.5.1. Market size and forecast, by Product
      • 7.4.5.5.2. Market size and forecast, by Application
      • 7.4.5.5.3. Market size and forecast, by End User
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Market size and forecast, by Product
      • 7.4.5.6.2. Market size and forecast, by Application
      • 7.4.5.6.3. Market size and forecast, by End User
  • 7.5. LAMEA
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by Product
    • 7.5.3. Market size and forecast, by Application
    • 7.5.4. Market size and forecast, by End User
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Market size and forecast, by Product
      • 7.5.5.1.2. Market size and forecast, by Application
      • 7.5.5.1.3. Market size and forecast, by End User
      • 7.5.5.2. Saudi Arabia
      • 7.5.5.2.1. Market size and forecast, by Product
      • 7.5.5.2.2. Market size and forecast, by Application
      • 7.5.5.2.3. Market size and forecast, by End User
      • 7.5.5.3. South Africa
      • 7.5.5.3.1. Market size and forecast, by Product
      • 7.5.5.3.2. Market size and forecast, by Application
      • 7.5.5.3.3. Market size and forecast, by End User
      • 7.5.5.4. Rest of LAMEA
      • 7.5.5.4.1. Market size and forecast, by Product
      • 7.5.5.4.2. Market size and forecast, by Application
      • 7.5.5.4.3. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product mapping of top 10 player
  • 8.4. Competitive dashboard
  • 8.5. Competitive heatmap
  • 8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

  • 9.1. Cochlear Limited
    • 9.1.1. Company overview
    • 9.1.2. Key executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
    • 9.1.6. Business performance
    • 9.1.7. Key strategic moves and developments
  • 9.2. MED-EL Elektromedizinische Gerate Gesellschaft m.b.H.
    • 9.2.1. Company overview
    • 9.2.2. Key executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
  • 9.3. Sonova Holding AG
    • 9.3.1. Company overview
    • 9.3.2. Key executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
    • 9.3.6. Business performance
  • 9.4. Medtronic plc
    • 9.4.1. Company overview
    • 9.4.2. Key executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
    • 9.4.6. Business performance
  • 9.5. Zhejiang Nurotron Biotechnology Co., Ltd
    • 9.5.1. Company overview
    • 9.5.2. Key executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
  • 9.6. Envoy Medical
    • 9.6.1. Company overview
    • 9.6.2. Key executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
  • 9.7. Ototronix, LLC
    • 9.7.1. Company overview
    • 9.7.2. Key executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
  • 9.8. Todoc co. ltd
    • 9.8.1. Company overview
    • 9.8.2. Key executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
  • 9.9. Neubio AG.
    • 9.9.1. Company overview
    • 9.9.2. Key executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
  • 9.10. Hemideina
    • 9.10.1. Company overview
    • 9.10.2. Key executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio

LIST OF TABLES

  • TABLE 01. GLOBAL HEARING IMPLANTS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 02. HEARING IMPLANTS MARKET FOR COCHLEAR IMPLANTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. HEARING IMPLANTS MARKET FOR BONE CONDUCTION DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 04. HEARING IMPLANTS MARKET FOR MIDDLE EAR IMPLANTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 05. HEARING IMPLANTS MARKET FOR AUDITORY BRAIN STEM IMPLANTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 06. GLOBAL HEARING IMPLANTS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 07. HEARING IMPLANTS MARKET FOR SENSORINEURAL , BY REGION, 2022-2032 ($MILLION)
  • TABLE 08. HEARING IMPLANTS MARKET FOR CONDUCTIVE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 09. GLOBAL HEARING IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 10. HEARING IMPLANTS MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. HEARING IMPLANTS MARKET FOR ENT CLINICS , BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. HEARING IMPLANTS MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. HEARING IMPLANTS MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. NORTH AMERICA HEARING IMPLANTS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 15. NORTH AMERICA HEARING IMPLANTS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 16. NORTH AMERICA HEARING IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 17. NORTH AMERICA HEARING IMPLANTS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 18. U.S. HEARING IMPLANTS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 19. U.S. HEARING IMPLANTS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 20. U.S. HEARING IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 21. CANADA HEARING IMPLANTS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 22. CANADA HEARING IMPLANTS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 23. CANADA HEARING IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 24. MEXICO HEARING IMPLANTS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 25. MEXICO HEARING IMPLANTS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 26. MEXICO HEARING IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 27. EUROPE HEARING IMPLANTS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 28. EUROPE HEARING IMPLANTS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 29. EUROPE HEARING IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 30. EUROPE HEARING IMPLANTS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 31. GERMANY HEARING IMPLANTS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 32. GERMANY HEARING IMPLANTS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 33. GERMANY HEARING IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 34. FRANCE HEARING IMPLANTS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 35. FRANCE HEARING IMPLANTS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 36. FRANCE HEARING IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 37. UK HEARING IMPLANTS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 38. UK HEARING IMPLANTS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 39. UK HEARING IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 40. ITALY HEARING IMPLANTS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 41. ITALY HEARING IMPLANTS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 42. ITALY HEARING IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 43. SPAIN HEARING IMPLANTS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 44. SPAIN HEARING IMPLANTS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 45. SPAIN HEARING IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 46. REST OF EUROPE HEARING IMPLANTS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 47. REST OF EUROPE HEARING IMPLANTS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 48. REST OF EUROPE HEARING IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 49. ASIA-PACIFIC HEARING IMPLANTS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 50. ASIA-PACIFIC HEARING IMPLANTS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 51. ASIA-PACIFIC HEARING IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 52. ASIA-PACIFIC HEARING IMPLANTS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 53. JAPAN HEARING IMPLANTS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 54. JAPAN HEARING IMPLANTS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 55. JAPAN HEARING IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 56. CHINA HEARING IMPLANTS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 57. CHINA HEARING IMPLANTS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 58. CHINA HEARING IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 59. INDIA HEARING IMPLANTS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 60. INDIA HEARING IMPLANTS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 61. INDIA HEARING IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 62. AUSTRALIA HEARING IMPLANTS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 63. AUSTRALIA HEARING IMPLANTS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 64. AUSTRALIA HEARING IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 65. SOUTH KOREA HEARING IMPLANTS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 66. SOUTH KOREA HEARING IMPLANTS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 67. SOUTH KOREA HEARING IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 68. REST OF ASIA-PACIFIC HEARING IMPLANTS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 69. REST OF ASIA-PACIFIC HEARING IMPLANTS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 70. REST OF ASIA-PACIFIC HEARING IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 71. LAMEA HEARING IMPLANTS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 72. LAMEA HEARING IMPLANTS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 73. LAMEA HEARING IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 74. LAMEA HEARING IMPLANTS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 75. BRAZIL HEARING IMPLANTS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 76. BRAZIL HEARING IMPLANTS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 77. BRAZIL HEARING IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 78. SAUDI ARABIA HEARING IMPLANTS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 79. SAUDI ARABIA HEARING IMPLANTS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 80. SAUDI ARABIA HEARING IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 81. SOUTH AFRICA HEARING IMPLANTS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 82. SOUTH AFRICA HEARING IMPLANTS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 83. SOUTH AFRICA HEARING IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 84. REST OF LAMEA HEARING IMPLANTS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 85. REST OF LAMEA HEARING IMPLANTS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 86. REST OF LAMEA HEARING IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 87. COCHLEAR LIMITED: KEY EXECUTIVES
  • TABLE 88. COCHLEAR LIMITED: COMPANY SNAPSHOT
  • TABLE 89. COCHLEAR LIMITED: PRODUCT SEGMENTS
  • TABLE 90. COCHLEAR LIMITED: PRODUCT PORTFOLIO
  • TABLE 91. COCHLEAR LIMITED: KEY STRATERGIES
  • TABLE 92. MED-EL ELEKTROMEDIZINISCHE GERATE GESELLSCHAFT M.B.H.: KEY EXECUTIVES
  • TABLE 93. MED-EL ELEKTROMEDIZINISCHE GERATE GESELLSCHAFT M.B.H.: COMPANY SNAPSHOT
  • TABLE 94. MED-EL ELEKTROMEDIZINISCHE GERATE GESELLSCHAFT M.B.H.: PRODUCT SEGMENTS
  • TABLE 95. MED-EL ELEKTROMEDIZINISCHE GERATE GESELLSCHAFT M.B.H.: PRODUCT PORTFOLIO
  • TABLE 96. SONOVA HOLDING AG: KEY EXECUTIVES
  • TABLE 97. SONOVA HOLDING AG: COMPANY SNAPSHOT
  • TABLE 98. SONOVA HOLDING AG: PRODUCT SEGMENTS
  • TABLE 99. SONOVA HOLDING AG: PRODUCT PORTFOLIO
  • TABLE 100. MEDTRONIC PLC: KEY EXECUTIVES
  • TABLE 101. MEDTRONIC PLC: COMPANY SNAPSHOT
  • TABLE 102. MEDTRONIC PLC: PRODUCT SEGMENTS
  • TABLE 103. MEDTRONIC PLC: PRODUCT PORTFOLIO
  • TABLE 104. ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD: KEY EXECUTIVES
  • TABLE 105. ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD: COMPANY SNAPSHOT
  • TABLE 106. ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD: PRODUCT SEGMENTS
  • TABLE 107. ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD: PRODUCT PORTFOLIO
  • TABLE 108. ENVOY MEDICAL: KEY EXECUTIVES
  • TABLE 109. ENVOY MEDICAL: COMPANY SNAPSHOT
  • TABLE 110. ENVOY MEDICAL: PRODUCT SEGMENTS
  • TABLE 111. ENVOY MEDICAL: PRODUCT PORTFOLIO
  • TABLE 112. OTOTRONIX, LLC: KEY EXECUTIVES
  • TABLE 113. OTOTRONIX, LLC: COMPANY SNAPSHOT
  • TABLE 114. OTOTRONIX, LLC: PRODUCT SEGMENTS
  • TABLE 115. OTOTRONIX, LLC: PRODUCT PORTFOLIO
  • TABLE 116. TODOC CO. LTD: KEY EXECUTIVES
  • TABLE 117. TODOC CO. LTD: COMPANY SNAPSHOT
  • TABLE 118. TODOC CO. LTD: PRODUCT SEGMENTS
  • TABLE 119. TODOC CO. LTD: PRODUCT PORTFOLIO
  • TABLE 120. NEUBIO AG.: KEY EXECUTIVES
  • TABLE 121. NEUBIO AG.: COMPANY SNAPSHOT
  • TABLE 122. NEUBIO AG.: PRODUCT SEGMENTS
  • TABLE 123. NEUBIO AG.: PRODUCT PORTFOLIO
  • TABLE 124. HEMIDEINA: KEY EXECUTIVES
  • TABLE 125. HEMIDEINA: COMPANY SNAPSHOT
  • TABLE 126. HEMIDEINA: PRODUCT SEGMENTS
  • TABLE 127. HEMIDEINA: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. HEARING IMPLANTS MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF HEARING IMPLANTS MARKET,2022-2032
  • FIGURE 03. TOP IMPACTING FACTORS IN HEARING IMPLANTS MARKET (2022 TO 2032)
  • FIGURE 04. TOP INVESTMENT POCKETS IN HEARING IMPLANTS MARKET (2023-2032)
  • FIGURE 05. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. HIGH THREAT OF NEW ENTRANTS
  • FIGURE 07. MODERATE THREAT OF SUBSTITUTES
  • FIGURE 08. MODERATE INTENSITY OF RIVALRY
  • FIGURE 09. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 10. GLOBAL HEARING IMPLANTS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. HEARING IMPLANTS MARKET, BY PRODUCT, 2022 AND 2032(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF HEARING IMPLANTS MARKET FOR COCHLEAR IMPLANTS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF HEARING IMPLANTS MARKET FOR BONE CONDUCTION DEVICES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF HEARING IMPLANTS MARKET FOR MIDDLE EAR IMPLANTS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF HEARING IMPLANTS MARKET FOR AUDITORY BRAIN STEM IMPLANTS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 16. HEARING IMPLANTS MARKET, BY APPLICATION, 2022 AND 2032(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF HEARING IMPLANTS MARKET FOR SENSORINEURAL , BY COUNTRY 2022 AND 2032(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF HEARING IMPLANTS MARKET FOR CONDUCTIVE, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 19. HEARING IMPLANTS MARKET, BY END USER, 2022 AND 2032(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF HEARING IMPLANTS MARKET FOR HOSPITALS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF HEARING IMPLANTS MARKET FOR ENT CLINICS , BY COUNTRY 2022 AND 2032(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF HEARING IMPLANTS MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 23. HEARING IMPLANTS MARKET BY REGION, 2022 AND 2032(%)
  • FIGURE 24. U.S. HEARING IMPLANTS MARKET, 2022-2032 ($MILLION)
  • FIGURE 25. CANADA HEARING IMPLANTS MARKET, 2022-2032 ($MILLION)
  • FIGURE 26. MEXICO HEARING IMPLANTS MARKET, 2022-2032 ($MILLION)
  • FIGURE 27. GERMANY HEARING IMPLANTS MARKET, 2022-2032 ($MILLION)
  • FIGURE 28. FRANCE HEARING IMPLANTS MARKET, 2022-2032 ($MILLION)
  • FIGURE 29. UK HEARING IMPLANTS MARKET, 2022-2032 ($MILLION)
  • FIGURE 30. ITALY HEARING IMPLANTS MARKET, 2022-2032 ($MILLION)
  • FIGURE 31. SPAIN HEARING IMPLANTS MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. REST OF EUROPE HEARING IMPLANTS MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. JAPAN HEARING IMPLANTS MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. CHINA HEARING IMPLANTS MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. INDIA HEARING IMPLANTS MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. AUSTRALIA HEARING IMPLANTS MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. SOUTH KOREA HEARING IMPLANTS MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. REST OF ASIA-PACIFIC HEARING IMPLANTS MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. BRAZIL HEARING IMPLANTS MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. SAUDI ARABIA HEARING IMPLANTS MARKET, 2022-2032 ($MILLION)
  • FIGURE 41. SOUTH AFRICA HEARING IMPLANTS MARKET, 2022-2032 ($MILLION)
  • FIGURE 42. REST OF LAMEA HEARING IMPLANTS MARKET, 2022-2032 ($MILLION)
  • FIGURE 43. TOP WINNING STRATEGIES, BY YEAR (2021-2022)
  • FIGURE 44. TOP WINNING STRATEGIES, BY DEVELOPMENT (2021-2022)
  • FIGURE 45. TOP WINNING STRATEGIES, BY COMPANY (2021-2022)
  • FIGURE 46. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 47. COMPETITIVE DASHBOARD
  • FIGURE 48. COMPETITIVE HEATMAP: HEARING IMPLANTS MARKET
  • FIGURE 49. TOP PLAYER POSITIONING, 2022
  • FIGURE 50. COCHLEAR LIMITED: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 51. COCHLEAR LIMITED: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 52. COCHLEAR LIMITED: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 53. SONOVA HOLDING AG: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 54. SONOVA HOLDING AG: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 55. SONOVA HOLDING AG: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 56. MEDTRONIC PLC: NET SALES, 2021-2023 ($MILLION)
  • FIGURE 57. MEDTRONIC PLC: REVENUE SHARE BY SEGMENT, 2023 (%)
  • FIGURE 58. MEDTRONIC PLC: REVENUE SHARE BY REGION, 2023 (%)